Reposted by Radcliffe Department of Medicine
🧬New research from the Chapman Group provides insight into why why ATM-deficient cancer cells are particularly vulnerable to PARP inhibitors.
The findings may help us better understand how some cancers respond to these drugs.🧪
@rdm.ox.ac.uk @medsci.ox.ac.uk #AcademicSky @rosschapmanlab.bsky.social
imm.ox.ac.uk